FDA OKs EarlySense monitoring device

11/20/2007 | Globes (Israel)

The FDA has granted Israel-based EarlySense Ltd. approval for its EverOn system, a heart and lung monitor that uses a proprietary contact-free sensor to reduce patient discomfort and enable monitoring at home and at hospitals. The system, which is being tested on patients with chronic diseases, is expected to be available next year.

View Full Article in:

Globes (Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC